Safety and effectiveness of the herpes zoster vaccine to prevent postherpetic neuralgia: 2014 Update and consensus statement from the Canadian Pain Society
نویسنده
چکیده
*Refer to Appendix 1 for the full list of participants Correspondence: Dr Gilles J Lavigne, Faculty of Dental Medicine, Universite de Montreal, 2900 Ed Montpetit, Montreal, Quebec H3C 3J7. Telephone 514-343-6005, e-mail [email protected] The Canadian Pain Society (CPS) hosted its first Study Day in Toronto in July 2014, attended by experts in various fields of pain management and research (listed below). The aim was to review the National Advisory Committee on Immunization guidelines and to prepare a CPS position statement concerning the use of the zoster vaccine in Canada.
منابع مشابه
Cost Effectiveness Analysis of A Vaccine To Prevent Herpes Zoster and Postherpetic Neuralgia in Italy.
Background. Herpes zoster (HZ), or shingles, is a painful disease that results from reactivation of the varicella zoster virus (VZV) which has remained latent in sensory ganglia following primary infection i.e. varicella (VZV), a virus commonly acquired in childhood (chickenpox) [1]. The most common complication is post-herpetic neuralgia (PHN), a severe pain that can persist for months [2]. HZ...
متن کاملCost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
BACKGROUND A vaccine to prevent herpes zoster was recently approved by the United States Food and Drug Administration. We sought to determine the cost-effectiveness of this vaccine for different age groups. METHODS We constructed a cost-effectiveness model, based on the Shingles Prevention Study, to compare varicella zoster vaccination with usual care for healthy adults aged >60 years. Outcom...
متن کاملIncidence, risk factors and prevention of herpes zoster: review article
Herpes zoster (Shingles; Zona) is an acute infectious skin disease that is caused by the reactivation of varicella zoster virus (VZV). After the initial infection (chickenpox) or vaccination, the virus remains inactive or latent in the dorsal root ganglia (DRG); when decreasing cell mediated immunity (CMI) occurs, the virus is reactivated from a latent phase to a lytic phase and frequently repl...
متن کاملA vaccine to prevent herpes zoster and post-herpetic neuralgia in older adults.
BACKGROUND The incidence and severity of herpes zoster and postherpetic neuralgia increase with age in association with a progressive decline in cell-mediated immunity to varicella-zoster virus (VZV). We tested the hypothesis that vaccination against VZV would decrease the incidence, severity, or both of herpes zoster and postherpetic neuralgia among older adults. METHODS We enrolled 38,546 a...
متن کاملUpdate on herpes zoster vaccination: a family practitioner's guide.
OBJECTIVE To answer frequently asked questions surrounding the use of the new herpes zoster (HZ) vaccine. SOURCES OF INFORMATION Published results of clinical trials and other studies, recommendations from the Canadian National Advisory Committee on Immunization, and the US Advisory Committee on Immunization Practices; data were also obtained from the vaccine's Health Canada-approved product ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 20 شماره
صفحات -
تاریخ انتشار 2015